Xin of Yu

Dr. Xin of Yu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2025 in Pharmacological Research
Verified
Journal Article
Open access
DLDongfang Lv
Dongfang Lv
YSYankang Shi
Yankang Shi
LKLuan Kou
Luan Kou
XYXin of Yu
Xin of Yu
YGYanxia Guo
Yanxia Guo
SZSheng-tian Zhao
Sheng-tian Zhao
Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation, has emerged as a promising vulnerability in cancer therapy. In prostate cancer (PCa), androgen receptor (AR) signaling remains a central oncogenic driver, with androgen deprivation therapy (ADT) as the standard of care. Emerging evidence suggests a bidirectional interaction between ferroptosis and AR signaling: ADT may sensitize cancer cells to ferroptosis by disrupting iron and lipid homeostasis, while ferroptosis-induced oxidative stress may in turn attenuate AR transcriptional activity. This review synthesizes current mechanistic insights into this interplay, highlighting key AR-regulated mediators of ferroptosis resistance, including MBOAT2, SLC7A11, and PEX10. We also discuss the therapeutic potential of dual-function agents, such as darolutamide and erastin, which simultaneously inhibit AR activity and induce ferroptosis, representing a novel strategy for treating castration-resistant prostate cancer (CRPC). Finally, we propose that combining ferroptosis inducers with AR-targeted therapies, guided by metabolic and redox biomarkers, may overcome therapeutic resistance and enable precision oncology approaches for advanced PCa.

16 February 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
DLDongfang Lv
Dongfang Lv
HJHuihui Jiang
Huihui Jiang
XYXianzhen Yang
Xianzhen Yang
YLYi Li
Yi Li
WNWeipin Niu
Weipin Niu
XYXin of Yu
Xin of Yu
Acute kidney injury (AKI) is characterized by a rapid decline in renal function and is associated with a high morbidity and mortality rate. At present, the underlying mechanisms of AKI remain incompletely understood. Immune disorder is a prominent feature of AKI, and dendritic cells (DCs) play a pivotal role in orchestrating both innate and adaptive immune responses, including the induction of protective proinflammatory and tolerogenic immune reactions. Emerging evidence suggests that DCs play a critical role in the initiation and development of AKI. This paper aimed to conduct a comprehensive review and analysis of the role of DCs in the progression of AKI and elucidate the underlying molecular mechanism. The ultimate objective was to offer valuable insights and guidance for the treatment of AKI.

24 January 2024 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
XYXin of Yu
Xin of Yu
SLShuai Liu
Shuai Liu
HJHuihui Jiang
Huihui Jiang
SLShuangde Liu
Shuangde Liu
FKFeng Kong
Feng Kong

1 May 2025 in Genes & Diseases
Verified
Journal Article
Open access
SLShuai Liu
Shuai Liu
XYXianzhen Yang
Xianzhen Yang
SZSanxia Zheng
Sanxia Zheng
CCChangjing Chen
Changjing Chen
LQLei Qi
Lei Qi
XYXin of Yu
Xin of Yu
Ferroptosis is an emerging form of programmed cell death triggered by iron-dependent lipid peroxidation. It is distinguished from other forms of cell death by its unique morphological changes and characteristic fine-tuned regulatory gene network. Since its pivotal involvement in the pathogenesis and therapeutic interventions of various diseases, such as malignant tumors, cardiovascular and cerebrovascular diseases, and traumatic disorders, has been well-established, ferroptosis has garnered significant attention in contemporary physiological and pathological research. For the advantage of alleviating the clinical symptoms and improving life quality, traditional Chinese medicine (TCM) holds a significant position in the treatment of these ailments. Moreover, increasing studies revealed that TCM compounds and monomers showed evident therapeutic efficacy by regulating ferroptosis via signaling pathways that tightly regulate redox reactions, iron ion homeostasis, lipid peroxidation, and glutathione metabolism. In this paper, we summarized the current knowledge of TCM compounds and monomers in regulating ferroptosis, aiming to provide a comprehensive review of disease management by TCM decoction, Chinese patent medicine, and natural products deriving from TCM through ferroptosis modulation. The formulation composition, chemical structure, and possible targets or mechanisms presented here offer valuable insights into the advancement of TCM exploration.

23 January 2026 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
WNWeipin Niu
Weipin Niu
XYXin of Yu
Xin of Yu
HZHuifei Zhang
Huifei Zhang
LQLei Qi
Lei Qi
DWDongli Wang
Dongli Wang
YJYue-Hua Jiang
Yue-Hua Jiang

3 July 2024 in Stem Cell Research
Verified
Journal Article
Open access
DZDenglu Zhang
Denglu Zhang
KLKaiLin Li
KaiLin Li
XYXianZhen Yang
XianZhen Yang
HWHaitao Wang
Haitao Wang
XYXin of Yu
Xin of Yu
X-linked hereditary Alport syndrome (XLAS) type 1 (OMIM: 301050) results from a pathogenic variant in the collagen type IV alpha 5 chain (COL4A5) gene.A human induced pluripotent stem cell (iPSC) line was generated from peripheral blood mononuclear cells of a 7-year-old male patient with XLAS using non-integrating episomal vector technique. The male donor had a heterozygous variant in the COL4A5 gene. The resulting iPSC line has a standard karyotype, can express pluripotent biomarkers, and is able to create germ layers in vivo. It can serve as a valuable cellular model for investigating the underlying mechanisms of XLAS.